Is Apo-CIII the new cardiovascular target? An analysis of its current clinical and dietetic therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is Apo-CIII the new cardiovascular target? An analysis of its current clinical and dietetic therapies

Published:2022-02 Issue:2 Volume:32 Page:295-308
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

de la Parra Soto Lorenzo.G.,Gutiérrez-Uribe Janet A.,Sharma Ashutosh,Ramírez-Jiménez Aurea K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference101 articles.

1. Cardiovascular diseases (CVDs);Organization WHO,2017

2. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease;Toth;Vasc Health Risk Manag,2016

3. Why is apolipoprotein CIII emerging as a novel therapeutic target to reduce the burden of cardiovascular disease?;Taskinen;Curr Atherosclerosis Rep,2016

4. Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII;Li;Cardiovasc Res,2015

5. Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice;Yingchun;Lipids Health Dis,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies;Journal of Clinical Medicine;2024-09-04

2. Metabolic dysfunction-associated steatotic liver disease and atherosclerosis;Current Diabetes Reports;2024-05-03

3. Genetic association of lipid-lowering drug target genes with erectile dysfunction and male reproductive health;Frontiers in Endocrinology;2024-02-08

4. Effects of a dietary intervention with lacto-ovo-vegetarian and Mediterranean diets on apolipoproteins and inflammatory cytokines: results from the CARDIVEG study;Nutrition & Metabolism;2024-02-01

5. The chylomicron saga: time to focus on postprandial metabolism;Frontiers in Endocrinology;2024-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3